Drug Study

Generic/Br Classifica Dosa Mechanis Indicatio Contraindi Adverse Effect Nursing

and name tion ge m of n cation Responsibilities
Action

Amlodipin Antiangi 205 Inhibits Hyperte Contraindi • CNS: • Know

e nals mg Calcium nsion cated to headache, 10R’s.
P.O ion flux patients fatigue, • Assist
Norvasc daily across hypertensi dizziness, patient
cardiac ve to CV: edema for any
Chronic
and drugs. • GI: drug
Angina,
smooth- abdominal allergies.
vasospa
muscles pain • Administe
stic
cells, t Us • Muscoskelet r drug
angina.
decreasing al: muscle which are
myocardia pain ordered.
l • Respiratory: • Report to
contractilit dyspnea Nod for
y and • Skin: rash any drug
oxygen effect and
demands; notify
also physician.
dilates • Glucose
coronary and Blood
arteries Pressure
and Monitorin
arterioles. g.

Donna Febe Talingdan 3E

 Drug study

Generic/ Classifi Dosage Mechanism Indicatio Contrain Adverse • Nursing

Brand cation of Action n dication Effect Responsibi
name lities

Insulin Hormo Breakfast- Regulates Hypergly Contrain • CV: • Know

Detemer nal 28ml, SC, glucose cemia dicated edema 10R’s.
Injection drugs before meal. metabolism with to • Metab • Assist
by binding patient patients olic: patient for
Levemirs Supper-14ml, insulin with hyperten Hypogl any drug
SC, before receptors diabetes sive to ycemi allergies.
meals. facilitating mellitus drugs on a, • Administer
cellular who it sodiu drug which
Bedtime-
uptake of need compone m are
14ml, SC.
glucose basal nts. retenti ordered.
Daily.
into the insulin. on, • Report to
muscles weight Nod for
and fat and gain,. any drug
inhibiting • Skin: effect and
release of injecti notify
glucose to on site physician.

Donna Febe Talingdan 3E

 liver. reactio • Glucose
n, and Blood
rash. Pressure
Monitoring
.

Name: Benjamin Talingdan Age: 55

Admitting Diagnosis: acute pneumonia Chief Complaint; dyspnea

and cough

Date/ Cues Nee Nursin Goal Of Nursing Rationale Evalua

Shift ds g Care Intervention tion
Diagno
sis

• GOAL
Octob S- P Ineffec At the • Established • To gain trust and MET
er 13 “budla tive end of Rapport. cooperation. patient
2009. y mag- H airway 8 hour • Provide • Provide a will
ginha cleara span of bedside comfortable able to
wa nce care, care.

Donna Febe Talingdan 3E

3pm- aha’ Y relate the • Vital sign surrounding mainta
11pm as the d to patient monitoring, in
patient S produc will I&O q shift patent
verbali tive able to • Auscultate airway
I
ze. cough mainta breath as
O secon in sounds and eviden
dary patent asses air • To ascertain status ce by
L to airway. movement. and note progress. the
acute • Elevate patient
O pnemo head to bed verbali
nia. zation
G “mas
okay
I • To take advantage na
• Encourage of the gravity
C
breathing decreasing • ang
and pressure in the akong
coughing diaphragm. pag-
N exercise. • ginha
• Position wa
E patients in • To maximize effort. kaysa
E proper body kagani
alignments. na”.
D • Instruct
patient to
increase
oral intake.
• Instruct • Promotes better
patient to lung expansion and

Donna Febe Talingdan 3E

 avoid improve air
restrictive expansion.
clothing.
• Provide
opportuniti
• To help liquefy
es for rest.
secretion

• To prevent
adequate
respiratory
excursion

• To prevent fatigue.

Donna Febe Talingdan 3E

Name: Benjamin Talingdan Age: 55

Admitting Diagnosis: Diabetes mellitus ll Chief

Complaint: nausea

Date/ Cues Nee Nursin Goal Of Nursing Rationale Evaluation

Shift ds g Care Intervention
Diagno
sis

• GOAL MET
Octob “O/S- P Risk At the • Established • To gain trust patient will
er 13 impair for end of Rapport. and able to
2009. ed H able 8 hour cooperation. perform
vision blood span of • Provide • Provide a procedures of
3pm- Y
glucos care bedside comfortable home
11pm edem e the care. surrounding
S glucose
a on relate patient • Insulin monitoring
upper I d to will absorption correctly.
body lack of able to can vary
• Administer • Perform
O diabet mainta from day-day insulin
swolle antidiabetic
es and in in healthy administratio
n L Drugs.
medic glucos sites and is n correctly as
injecti • Check

Donna Febe Talingdan 3E

on site O ation e in injection less. the patient
manag satisfa site absorbable. verbalized
weight G ement ctory periodically. Lymphohype “dli na
loss. secon level. rtrophic maglagum
I
dary tissues. bisag ako na
C to • Patient may lang mag-
Diabet able to inject”
es • Ascertain forget
Mellitu that all medication • Acknowledge
N s ll. or self-inject factors that
medicines
are bought and might may lead to
E need unstable
out and
given. reminders glucose.
E
and • Maintain
D supervisions. glucose level
• To identify at
S and manage satisfactory
glucose. to range.
avoid
complication
• Discuss
s
home
glucose and
instruct
patient and
family on
how to self
administrati
on

Donna Febe Talingdan 3E

 how to
administer
insulin
injection
• To provide a
• Encourage
sense of
client to
control and
develop a
enable client
system for
to follow own
self
progress and
monitoring.
assist in
making
choices.
• Avoid altered
perfusion of
• Elevate feet extremities
when
sleeping
and sitting.
• Vital sign
monitoring,
I&O q shift

Donna Febe Talingdan 3E